when was semaglutide patented Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India With semaglutide's patent expiring, generics

Most patients start eating smaller portions or feeling satisfied longer between meals

Dec 29, 2025 CagriSema represents the next evolution in medical weight loss - Novo Nordisk's branded combination of semaglutide 2.4mg and cagrilintide 2.4mg that produced 15-25% body weight loss in Phase 3 trials

~ AlphaMD Most men start testosterone replacement therapy to feel stronger, sharper, and more like themselves again - but nobody signs up expecting to watch their hairline move

At Clover Meds, our aim is to assist our patients in achieving weight loss within these sustainable parameters, promoting a journey that prioritizes long-term success